€42.68
0.21% yesterday
Xetra, Jun 30, 05:35 pm CET
ISIN
DE0005785604
Symbol
FRE
Sector

Fresenius Stock price

€42.68
-0.50 1.16% 1M
+9.14 27.25% 6M
+9.14 27.25% YTD
+14.38 50.81% 1Y
+13.78 47.68% 3Y
-1.44 3.26% 5Y
-14.87 25.84% 10Y
+32.15 305.40% 20Y
Xetra, Closing price Mon, Jun 30 2025
+0.09 0.21%
ISIN
DE0005785604
Symbol
FRE
Sector

Key metrics

Basic
Market capitalization
€23.5b
Enterprise Value
€33.2b
Net debt
€9.7b
Cash
€3.9b
Shares outstanding
563.2m
Valuation (TTM | estimate)
P/E
57.55 | 12.85
P/S
1.06 | 1.03
EV/Sales
1.50 | 1.45
EV/FCF
21.35
P/B
1.24
Dividends
DPS
€1.00
Yield 1Y | 5Y
2.35% | 2.23%
Growth 1Y | 5Y
100.00% | 3.55%
Payout 1Y | 3Y
120.48% | 86.49%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€22.1b | €22.9b
EBITDA
€2.0b | €3.8b
EBIT
€1.9b
Net Income
€422.0m | €1.9b
Free Cash Flow
€1.6b
Growth (TTM | estimate)
Revenue
-20.12% | 4.93%
EBITDA
12.03% | 108.28%
EBIT
12.60%
Net Income
233.54% | 296.28%
Free Cash Flow
-52.29%
Margin (TTM | estimate)
Gross
24.48%
EBITDA
8.84% | 16.57%
EBIT
8.65%
Net
1.91% | 8.15%
Free Cash Flow
7.03%
Financial Health
Equity Ratio
44.87%
Return on Equity
2.41%
ROCE
5.49%
ROIC
3.82%
Debt/Equity
0.70
More
EPS
€0.74
FCF per Share
€2.76
Short interest
-
Employees
176.49k
Rev per Employee
€120.00k
Show more

Create a Free Account to create an Fresenius alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Fresenius Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Fresenius forecast:

19x Buy
83%
4x Hold
17%

Analyst Opinions

23 Analysts have issued a Fresenius forecast:

Buy
83%
Hold
17%

Financial data from Fresenius

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
22,107 22,107
20% 20%
100%
- Direct Costs 16,695 16,695
21% 21%
76%
5,412 5,412
16% 16%
24%
- Selling and Administrative Expenses 2,916 2,916
26% 26%
13%
- Research and Development Expense 595 595
15% 15%
3%
1,955 1,955
12% 12%
9%
- Depreciation and Amortization 42 42
9% 9%
0%
EBIT (Operating Income) EBIT 1,913 1,913
13% 13%
9%
Net Profit 422 422
234% 234%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Fresenius directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Stock News

AD HOC NEWS
13 days ago
Für die Aktien von Fresenius DE0005785604 Medical Care (FMC) DE0005785802 geht es am Mittwoch weiter bergab.
AD HOC NEWS
about 2 months ago
Deutsche Bank Research hat das Kursziel für Fresenius DE0005785604 von 49 auf 52 Euro angehoben und die Einstufung auf "Buy" belassen.
AD HOC NEWS
about 2 months ago
Das Analysehaus Jefferies hat die Einstufung für Fresenius DE0005785604 mit einem Kursziel von 48 Euro auf "Buy" belassen.
More Fresenius News

Company Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Michael Sen
Employees 176,486
Founded 1912
Website www.fresenius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today